NVTA - Invitae Corp
Previous close
0.019
0 0%
Share volume: 22,459,258
Last Updated: Wed 14 Feb 2024 06:00:00 AM CET
Medical Laboratories :
-2.05%
PREVIOUS CLOSE
CHG
CHG%
$0.02
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-03 | 2022-08-09 | 2022-11-08 | 2023-02-28 | 2023-05-09 | 2023-08-08 | 2023-11-08 | |
| Assets | ||||||||
| Total Assets | 4.768 B | 2.291 B | 2.026 B | 1.954 B | 1.692 B | 1.523 B | 535.115 M | |
| Current Assets | 1.031 B | 894.247 M | 729.676 M | 693.130 M | 504.268 M | 451.225 M | 378.399 M | |
| Inventories | 43.457 M | 49.073 M | 29.902 M | 30.386 M | 19.070 M | 20.814 M | 21.627 M | |
| Other Current Assets | 32.037 M | 35.825 M | 24.679 M | 19.496 M | 20.908 M | 19.664 M | 19.692 M | |
| Short Term Investments | 32.037 M | 35.825 M | 24.679 M | 19.496 M | 20.908 M | 19.664 M | 19.692 M | |
| Total Receivables | 80.399 M | 82.586 M | 89.130 M | 96.148 M | 85.592 M | 85.610 M | 82.507 M | |
| Current Cash | 874.712 M | 726.763 M | 585.965 M | 547.100 M | 378.698 M | 325.137 M | 254.573 M | |
| Total Non-current Assets | 3.737 B | 1.396 B | 1.297 B | 1.261 B | 1.187 B | 1.072 B | 156.716 M | |
| Property Plant Equipment | 129.959 M | 132.935 M | 113.878 M | 108.723 M | 95.445 M | 92.091 M | 65.446 M | |
| Other Assets | 28.693 M | 27.520 M | 21.518 M | 23.121 M | 21.977 M | 20.573 M | 19.531 M | |
| Intangible Assets | 1.168 B | 1.108 B | 1.041 B | 1.013 B | 981.888 M | 873.924 M | 0.000 | |
| Goodwill | 2.283 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 4.768 B | 2.291 B | 2.026 B | 1.954 B | 1.692 B | 1.523 B | 535.115 M | |
| Total liabilities | 1.924 B | 1.905 B | 1.867 B | 1.852 B | 1.728 B | 1.724 B | 1.619 B | |
| Total current liabilities | 167.900 M | 139.251 M | 113.321 M | 108.093 M | 190.180 M | 151.968 M | 158.419 M | |
| Accounts Payable | 41.701 M | 26.751 M | 10.727 M | 13.984 M | 11.903 M | 23.067 M | 25.185 M | |
| Other liabilities | 29.266 M | 19.921 M | 12.667 M | 4.775 M | 4.326 M | 4.241 M | 226.000 K | |
| Current long term debt | 5.400 M | 5.340 M | 5.279 M | 5.121 M | 76.772 M | 4.514 M | 30.855 M | |
| Long term debt | 1.589 B | 1.592 B | 1.594 B | 1.597 B | 1.383 B | 1.422 B | 1.325 B | |
| Other liabilities | 29.266 M | 19.921 M | 12.667 M | 4.775 M | 4.326 M | 4.241 M | 226.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 2.844 B | 385.905 M | 158.866 M | 101.836 M | -36.656 M | -200.786 M | -1.083 B | |
| Common stock | 228.470 M | 232.117 M | 237.974 M | 244.143 M | 249.907 M | 263.836 M | 275.604 M | |
| Retained earnings | -1.905 B | -4.428 B | -4.729 B | -4.829 B | -5.021 B | -5.228 B | -6.170 B |